SCHEMBL14052575

SCHEMBL14052575

O=C(O)c1c(C=Cc2ccccc2)ccc2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.55
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
GLA P06280 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CYP1B1 Q16678 3/20 0.48
CYP1A1 P04798 2/20 0.47
WDR5 P61964 1/20 0.43
P2RX3 P56373 1/20 0.43
METAP2 P50579 1/20 0.43
METAP1 P53582 1/20 0.43
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
LDHA P00338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14052574 1.00 ABCG2 (0.55) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL8210024 0.90 ABCG2 (0.55) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL8210028 0.90 ABCG2 (0.55) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL30423720 0.83 NCEH1 (0.50) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL14149856 0.83 NCEH1 (0.50) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL14052619 0.83 ABCG2 (0.49) ABCG2ALDH1A1CYP1B1CYP1A1
SCHEMBL14052620 0.83 ABCG2 (0.49) ABCG2ALDH1A1CYP1B1CYP1A1
SCHEMBL29054179 0.83 NCEH1 (0.50) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL1407222 0.81 MEN1 (0.55) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL15476962 0.81 KDM4E (0.47) ABCG2KDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166500-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters QUEEN'S UNIVERSITY AT KINGSTON (CA) 2015-06-18 US disclosed
US-20120302752-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166500-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters DDC, AOC2, AOC3 ABCG2 536/4885KDM4E 1347/4885ALDH1A1 2475/4885
US-20120302752-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters DDC, AOC2, AOC3 ABCG2 536/4885KDM4E 1347/4885ALDH1A1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.